Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Endoscopic ultrasound-guided techniques for pancreatic diseases

View through CrossRef
Endoscopic Ultrasound (EUS) is a transformative technology in the field of gastroenterology, particularly in the management of pancreatic diseases. This review provides a comprehensive examination of the use of EUS in diagnosing and treating pancreatic conditions, highlighting its diagnostic precision and therapeutic potential. The efficacy of EUS depends significantly on the operator's expertise, which underscores the need for extensive training and the acquisition of experience. Technological advancements, such as high-definition imaging and enhanced needle guidance systems, have markedly improved the ability of EUS to differentiate between benign and malignant pancreatic lesions, making it an indispensable tool in clinical decision-making. This article discusses the critical aspects of procedural safety, emphasizing the importance of meticulous pre-procedural assessments and the strategic use of prophylactic antibiotics to minimize risks such as infection and pancreatitis. The review also points out the essential role of careful post-procedure monitoring in enhancing patient safety. The emerging integration of artificial intelligence with EUS promises to refine diagnostic accuracy further and expand this technique's therapeutic capabilities. By advancing our understanding and application of EUS, we can significantly improve outcomes for patients with pancreatic diseases. The continued evolution of EUS technology and methodology positions it as a cornerstone of minimally invasive gastroenterology, offering promising prospects for patient care in pancreatic pathologies.
Title: Endoscopic ultrasound-guided techniques for pancreatic diseases
Description:
Endoscopic Ultrasound (EUS) is a transformative technology in the field of gastroenterology, particularly in the management of pancreatic diseases.
This review provides a comprehensive examination of the use of EUS in diagnosing and treating pancreatic conditions, highlighting its diagnostic precision and therapeutic potential.
The efficacy of EUS depends significantly on the operator's expertise, which underscores the need for extensive training and the acquisition of experience.
Technological advancements, such as high-definition imaging and enhanced needle guidance systems, have markedly improved the ability of EUS to differentiate between benign and malignant pancreatic lesions, making it an indispensable tool in clinical decision-making.
This article discusses the critical aspects of procedural safety, emphasizing the importance of meticulous pre-procedural assessments and the strategic use of prophylactic antibiotics to minimize risks such as infection and pancreatitis.
The review also points out the essential role of careful post-procedure monitoring in enhancing patient safety.
The emerging integration of artificial intelligence with EUS promises to refine diagnostic accuracy further and expand this technique's therapeutic capabilities.
By advancing our understanding and application of EUS, we can significantly improve outcomes for patients with pancreatic diseases.
The continued evolution of EUS technology and methodology positions it as a cornerstone of minimally invasive gastroenterology, offering promising prospects for patient care in pancreatic pathologies.

Related Results

The 39Th Congress Of The Japan Gastroenterological Endoscopy Society
The 39Th Congress Of The Japan Gastroenterological Endoscopy Society
SYMPOSIUM I: RADIOLOGICAL DIAGNOSIS OF FLAT TYPE (TYPE IIb) EARLY GASTRIC CANCER: A NEW MEANS OF EVALUATION Yoshinori SUGINO and Kenji KUMAKURASYMPOSIUM I: ENDOSCOPIC AND ROENTGENO...
Abstract IA-08: Clinical advances in pancreas adenocarcinoma
Abstract IA-08: Clinical advances in pancreas adenocarcinoma
Abstract Pancreatic adenocarcinoma (PDAC) remains one of the most lethal cancers today and is expected to be the second cause of cancer death in the coming decade. M...
High Expression of AMIGO2 Is an Independent Predictor of Poor Prognosis in Pancreatic Cancer
High Expression of AMIGO2 Is an Independent Predictor of Poor Prognosis in Pancreatic Cancer
Abstract Background.The AMIGO2 extracellular domain has a leucine - rich repetitive domain (LRR) and encodes a type 1 transmembrane protein , and is a member of the AMIGO g...
Risk Factors of Pancreatic Fistula in Distal Pancreatectomy Patients
Risk Factors of Pancreatic Fistula in Distal Pancreatectomy Patients
Introduction.Benign and malignant lesions of the pancreas located at the body and tail of the pancreas are managed by the standard procedure of distal pancreatectomy (DP). The mort...
Abstract 1603: Intra-pancreatic fat promotes the progression of PDAC by activating thermogenesis
Abstract 1603: Intra-pancreatic fat promotes the progression of PDAC by activating thermogenesis
Abstract Background: The presence of minimal intra-pancreatic fat deposition (IPFD) in the healthy human pancreas has been demonstrated in numerous studies. But exce...
CHARACTERIZATION OF CYSTIC PANCREATIC LESIONS ON EUS, A SINGLE CENTRE EXPERIENCE
CHARACTERIZATION OF CYSTIC PANCREATIC LESIONS ON EUS, A SINGLE CENTRE EXPERIENCE
Background: Pancreatic cystic lesions are increasingly diagnosed these days due to better imaging techniques. It is important to detect the lesions and perform a detailed analysis ...
Infected Pancreatic Necrosis Mimicking Pancreatic Cancer
Infected Pancreatic Necrosis Mimicking Pancreatic Cancer
Although infected pancreatic necrosis can develop as a result of rare conditions involving trauma, surgery, and systemic infection with an uncommon pathogen, it usually occurs as a...

Back to Top